CRGX (Cargo Therapeutics) Likuiditas cepet

CARGO Therapeutics (CRGX) maintains a high scientific standing in developing advanced oncology treatments. This asset price chart demonstrates a current coefficient of 12.75, which is critical amid fierce competition with industry behemoths for leadership in treatment. Business development relies on the successful completion of clinical trials and the launch of facilities for mass drug production.

CARGO Therapeutics, Inc (CRGX) - Likuiditas kritis saka 21.02.2024 nganti 30.08.2025

cargo-tx.com (CRGX) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:

Bagan rega Cargo Therapeutics|CRGX - Bagan rega target

- indikator valuasi pasar bisnis:

Nilai pasar Cargo Therapeutics|CRGX - Total Nilai Perusahaan

- data kapitalisasi buku:

Nilai Buku saben Saham CARGO Therapeutics|CRGX - Nilai Buku Bisnis|Rasio Kapitalisasi marang Aset Bersih cargo-tx.com|CRGX - Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Rasio Total Utang marang Ekuitas CARGO Therapeutics|CRGX - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal CARGO Therapeutics, Inc.|CRGX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Cargo Therapeutics|CRGX - Utang jangka dawa|Utang jangka cendhak perusahaan CARGO Therapeutics|Likuiditas cepet cargo-tx.com

- indikator bathi lan kelipatan valuasi:

CRGX - Bathi resik perusahaan

Analisis dhasar perusahaan:Cargo Therapeutics - CRGX

The quick ratio measures a company's ability to meet short-term obligations using only cash and accounts receivable, excluding inventory. By analyzing the quick ratio's history, an investor determines the balance between financial stability and capital efficiency. The stability of this metric confirms the maturity of working capital management at CARGO Therapeutics (CRGX). This correlates with strict corporate quality control and industrial safety standards in the development of cell therapies.

Analisis perusahaan pesaing